Photobiomodulation therapy and antiviral photodynamic therapy as potential treatment modalities for COVID-19

  • Phạm Hữu Nghị Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

COVID-19, laser, Photobiomodulation, antiviral photodynamic

Abstract

COVID-19 disease is a dangerous infectious disease caused by the SARS-CoV-2 virus and is currently a pandemic in the world and in Vietnam. In this disease control strategy, the role of treatment when infected is very important. Antiviral photodynamic and photobiomodulatory therapy is a new therapeutic direction in the treatment of COVID-19 patients. The treatment direction which combines photobiomodulation and antiviral photodynamics with conventional drug administration reveals high potential as well as great helpful promise of new methods in the treatment of COVID-19 patients

Article Details

References

1. Parasher A (2021) COVID-19 current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 97: 312-320.
2. Polat E et al (2021) Natural photosensitizers in antimicrobial photodynamic therapy. Biomedicines 9: 584. https://doi.org/10.3390/biomedicines9060584
3. Tariq R et al (2021) Photodynamic therapy: A rational approach toward COVID-19 management. J Explor Res Pharmacol 6(2): 44-52.
4. Willis JA et al (2021) Photodynamic viral inactivation: Recent advances and potential applications. Appl. Phys. Rev. 8: 021315 (doi: 10.1063/5.0044713.
5. Conrado PCV et al (2021) A systematic review of photodynamic therapy as an antiviral treatment: Potential guidance for dealing with SARS-CoV-2. Photodiagnosis and Photodynamic Therapy 34: 102221.
6. Dias LD et al (2020) An update on clinical photodynamic therapy for fighting respiratory tract infections: a promising tool against COVID-19 and its co-infections. Laser Phys. Lett. 17: 083001 (9pp).
7. Moshfegh F et al (2021) Antiviral optical techniques as a possible novel approach to COVID-19 treatment. Journal of Innovative Optical Health Sciences· February 2021, DOI: 10.1142/S1793545821300020
8. Svyatchenko VA et al (2021) Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin. Photodiagnosis and Photodynamic Therapy 33: 102112.
9. Jin C et al (2021) Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infectious Diseases 21: 357.
10. Hamidi-Alamdari D et al (2021) Methylene blue for treatment of hospitalized COVID-19 Patients: A randomized, controlled, open-label clinical trial, phase 2. Rev Invest Clin 73(3): 190-198.
11. Schikora D et al (2020) Reduction of the viral load by non-invasive photodynamic therapy in early stages of COVID-19 infection. Am J of Viro and Dis 2(1): 01-05.
12. Keil S D et al (2020) Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment. Vox Sanguinis (2020), DOI: 10.1111/vox.12937.
13. Ragan I et al (2020) Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light. PLOS ONE, May 29, 2020. https://doi.org/10.1371/journal.pone.0233947.
14. Lei J et al (2021) The promise of endogenous and exogenous riboflavin in anti-infection. Virulence 12(1): 2314-2326.
15. Litscher G et al (2021) Comments on new integrative photomedicine equipment for photobiomodulation and COVID-19. Photonics 8: 303. https://doi.org/10.3390/photonics8080303.
16. Weber H M et al (2020) Successful reduction of SARS-CoV-2 viral load by photodynamic therapy (PDT) verified by QPCR - a novel approach in treating patients in early infection stages. Med Clin Res 5(11): 311-325.
17. Freitas de Freitas L and Hamblin MR (2016) Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron 22(3): doi:10.1109/JSTQE.2016.2561201.
18. Moskvin SV (2017) Low-level laser therapy in Russia: History, science and practice. J Lasers Med Sci 8(2): 56-65.
19. Almeida P et al (2013) What is the best treatment to decrease pro-inflammatory cytokine release in acute skeletal muscle injury induced by trauma in rats: Low-level laser therapy, diclofenac, or cryotherapy? Lasers Med Sci, DOI 10.1007/s10103-013-1377-3.
20. Lima FM et al (2010) Low intensity laser therapy (LILT) in vivo acts on the neutrophils recruitment and chemokines/cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from Escherichia coli in rat. Journal of Photochemistry and Photobiology B: Biology 101(3): 271-278.
21. Marlon da-Palma-Cruz et al (2018) Photobiomodulation modulates the resolution of inflammation during acute lung injury induced by sepsis. Lasers in Medical Science. DOI: https://doi.org/10.1007/s10103-018-2688-1.
22. Derbenjev VA et al (2000) The use of the low level laser therapy (LLLT) in the treatment of some pulmonary diseases (10 years experience). Proceedings of SPIE 4166.
23. Gunn C (2005) Acute respiratory distress syndrome successfully treated with low level laser therapy. Journal of Complementary and Integrative Medicine 2(1): 5.
24. Sherafat SJ et al (2020) The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection. J Lasers Med Sci 11(1): 23-29.
25. Vetrici et al (2021) Evaluation of adjunctive photobiomodulation (PBMT) for COVID-19 pneumonia via clinical status and pulmonary severity indices in a preliminary trial. Journal of Inflammation Research 14: 965-979.
26. Matos TL et al (2021) Photobiomodulation Therapy as a possible new approach in COVID-19: A systematic review. Life 11: 580.
27. Nejatifard M et al (2021) Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review. Cytokine 137: 155312.
28. Hanna R et al (2020) Phototherapy as a rational antioxidant treatment modality in COVID-19 management; new concept and strategic approach: critical review. Antioxidants 9: 875. doi:10.3390/ antiox9090875.
29. Sabino CP et al (2020) Light-based technologies for management of COVID-19 pandemic crisis. J Photochem Photobiol B 212: 111999.
30. Moskvin S et al (2021) Low-level laser therapy in prevention of the development of endothelial dysfunction and clinical experience of treatment and rehabilitation of COVID-19 patients. Rehabilitation Research and Practice DOI: https://doi.org/10. 1155/2021/6626932.
31. Mokmeli S et al (2020) Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19. Can J Respir Ther 56: 25-31.
32. Sigman SA et al (2020) A 57-year-old african american man with severe COVID-19 pneumonia who responded to supportive photobiomodulation therapy (PBMT): First use of PBMT in COVID-19. Am J Case Rep 21: 926779.
33. Mikhaylov VA (2021) Laser therapy in the complex prevention and treatment of COVID-19 (Preliminary Results). Journal of Corona Virus 1(1): 1-4
34. Liebert A et al (2020) A potential role for photobiomodulation therapy in disease treatment and prevention in the era of COVID-19. Aging and Disease 11(6).
35. Souza GHM et al (2020) Acute effects of photobiomodulation therapy applied to respiratory muscles of chronic obstructive pulmonary disease patients: A double-blind, randomized, placebo-controlled crossover trial. Lasers in Medical Science, https://doi.org/10.1007/s10103-019-02885-3
36. Trần Ngọc Liêm, Lê Huy Tuấn, Nguyễn Thế Hùng, Phạm Hữu nghị, Đỗ Thiện Dân và cộng sự (2007) Tổng quan ứng dụng laser y tế ở Việt nam. Tạp chí Y Dược lâm sàng 108, Số đặc biệt tháng 6-2007, tr. 5-11.
37. Phạm Hữu Nghị và cộng sự (2016) Khảo sát tác dụng của ánh sáng LED ở bước sóng 630nm lên quá trình liền vết thương hở của da lung thỏ. Tạp chí Y dược lâm sàng 108, 11(2), tr. 121-126.